Treatment of Tuberculous Meningitis
Treat tuberculous meningitis with rifampin and isoniazid for 12 months, supplemented by pyrazinamide and a fourth drug (ethambutol, streptomycin, or ethionamide) for at least the first 2 months, and add corticosteroids for moderate to severe disease (stages II and III). 1
Core Treatment Regimen
Drug Selection and Duration
- Use rifampin and isoniazid for 12 months total duration 1
- Add pyrazinamide for at least the first 2 months (penetrates well into cerebrospinal fluid) 1
- Include a fourth drug for the initial 2 months: streptomycin, ethambutol (15 mg/kg), or ethionamide 1
Critical Drug Penetration Considerations
- Isoniazid, pyrazinamide, and prothionamide/ethionamide penetrate well into CSF 1
- Rifampin penetrates less well into CSF 1
- Streptomycin and ethambutol only achieve adequate CSF concentrations when meninges are inflamed early in treatment 1
- Intrathecal streptomycin is unnecessary 1
Corticosteroid Therapy
Indications and Dosing
- Add corticosteroids for stages II and III disease (confused patients, those with neurologic signs, or comatose patients) 1, 2
- Use dexamethasone 6-12 mg/day or prednisone 60-80 mg/day initially, tapered over 4-8 weeks 3, 2
- Stage I patients (fully conscious, rational, no neurologic signs) do not require corticosteroids 2
Special Considerations
Ethambutol Use in Unconscious Patients
- Exercise caution with ethambutol in stage III (unconscious) patients because visual acuity cannot be monitored for ocular toxicity, despite the very low risk at 15 mg/kg dosing 1
If Pyrazinamide Cannot Be Used
- Extend treatment duration to 18 months if pyrazinamide is omitted or cannot be tolerated 1
Cerebral Tuberculoma Without Meningitis
- Use the same 12-month regimen for cerebral tuberculoma(s) without meningitis 1
Evidence Quality and Limitations
Current Guideline Basis
- Guidelines acknowledge lack of randomized controlled trial evidence, with recommendations based on experience from centers treating large numbers of patients 1
- Recent trials of intensified regimens (higher-dose rifampin 15 mg/kg plus levofloxacin) showed no survival benefit compared to standard treatment 4, 5
- Pharmacokinetic studies demonstrate that while higher rifampin doses increase plasma and CSF exposure, this does not translate to improved survival; however, isoniazid exposure is associated with survival, with low exposure predicting death in fast metabolizers 6
Common Pitfalls to Avoid
- Do not use the standard 6-month pulmonary TB regimen for meningitis—this is inadequate for CNS disease 1
- Do not omit the fourth drug in the initial phase without careful consideration of drug resistance patterns 1
- Do not taper corticosteroids too quickly—symptoms of CNS inflammation may recur 2
- Ensure lumbar puncture in miliary TB cases to identify CNS involvement, as blood-borne spread to meninges occurs at high rates 1